Sumitomo Life Insurance’s Dr. Reddy's Laboratories RDY Stock Holding History

Sumitomo Life Insurance’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-12,000	Closed	-$101K	–	264
2017 Q2	$101K	Sell	12,000 -9,000	-43%	-$73.2K	0.01%	261
2017 Q1	$169K	Buy	21,000 +6,000	+40%	+$51.8K	0.02%	283
2016 Q4	$136K	Buy	+15,000	New	+$140K	0.02%	276
2015 Q4	–	Sell	-48,500	Closed	-$620K	–	289
2015 Q3	$620K	Buy	+48,500	New	+$602K	0.08%	276
2014 Q3	–	Sell	-63,500	Closed	-$548K	–	286
2014 Q2	$548K	Sell	63,500 -43,500	-41%	-$366K	0.05%	283
2014 Q1	$939K	Sell	107,000 -90,000	-46%	-$783K	0.09%	251
2013 Q4	$1.62M	Buy	197,000 +12,500	+7%	+$98.9K	0.15%	219
2013 Q3	$1.39M	Sell	184,500 -25,000	-12%	-$182K	0.13%	235
2013 Q2	$1.58M	Buy	+209,500	New	+$1.53M	0.15%	226

Other funds holding RDY

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Sumitomo Life Insurance's RDY Position: Q3 2017 in Review

Sumitomo Life Insurance sold out of Dr. Reddy's Laboratories (RDY) in Q3 2017, closing a stake of 12,000 shares — an estimated $101K sold.

Sumitomo Life Insurance first reported a position in RDY in Q2 2013 and held it in 9 quarters. The position peaked at $1.62M in Q4 2013. 118 funds tracked by Wall St. Rank hold RDY as of Q3 2017.

Sumitomo Life Insurance reported no remaining Dr. Reddy's Laboratories position as of Q3 2017 after selling out during the quarter.
Sumitomo Life Insurance sold 12,000 Dr. Reddy's Laboratories shares in Q3 2017, an estimated $101K.
Sumitomo Life Insurance first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 9 quarters.
Sumitomo Life Insurance's Dr. Reddy's Laboratories position peaked at $1.62M in Q4 2013.
118 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2017.

Based on Sumitomo Life Insurance's 13F filing for Q3 2017, filed 17 Oct 2017.